These insights not only uncover the crucial role of UBE2J1 as the key E2 ubiquitin-conjugating enzyme for AR degradation but also illuminate an uncharted mechanism through which advanced PCa cells elevate AR protein levels to resist existing antiandrogen therapy. This evidence concerns the gene UBE2S and posterior cortical atrophy.